Ever Fortune. AI Co

Ever Fortune. AI Co ROE

The Return on Equity (ROE) of Ever Fortune. AI Co (6841.TWO) as of Oct 22, 2026 is 4.97 %. In the previous year, Return on Equity (ROE) was 1.62 % — a change of 206.43% (higher).

ROE

4.97 %

YoY

206.43%

Last updated:

In 2025, Ever Fortune. AI Co's return on equity (ROE) was 4.97 %, a 206.43% increase from the 1.62 % ROE in the previous year.

The Ever Fortune. AI Co ROE history

  • 3 Years

  • 10 Years

  • 25 Years

  • Max

ROE
Date
ROE
Jan 1, 2018
-1.13 TWD
Jan 1, 2020
-3.43 TWD
Jan 1, 2021
-3.59 TWD
Jan 1, 2022
8.29 TWD
Jan 1, 2023
-2.17 TWD
Jan 1, 2024
1.62 TWD
Jan 1, 2025
4.97 TWD
The Ever Fortune. AI Co ROE history
YEARROEYoY
4.97 %+206.43%
1.62 %-174.58%
-2.17 %-126.23%
8.29 %-330.80%
-3.59 %+4.57%
-3.43 %+204.66%
-1.13 %—

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Ever Fortune. AI Co Stock analysis

What does Ever Fortune. AI Co do? Ever Fortune.AI Co., Ltd. generates revenue through the sale of medical AI software products and customized technology solutions. The company offers medical big data platforms, cloud biomedical services, and AI-driven tools such as the radiographic bone age-assisted interpretation system, ultrasound breast tumor auxiliary classification system, and CT liver cancer metastasis risk management system. These products target healthcare providers, hospitals, and medical institutions seeking advanced diagnostic and analytical capabilities. The firm's focus on specialized medical AI applications ensures consistent demand from clients requiring precision in radiology, oncology, and cardiology. The company's revenue streams include the provision of medical AI data analysis services and tailored AI technology solutions for healthcare facilities. Products like the liver fibrosis evaluation system and irregular cardiac fibrillation interpretation system are designed to address specific clinical needs, enhancing diagnostic accuracy. Healthcare organizations, particularly those in radiology and cardiology departments, purchase these tools to improve patient outcomes and operational efficiency. Ever Fortune.AI's business model centers on delivering high-value AI solutions for medical diagnostics, with a portfolio that includes both standardized products and custom-developed systems. The firm's offerings cater to hospitals and medical institutions looking to integrate AI into their diagnostic workflows. By focusing on niche medical applications, the company establishes itself as a specialized provider in the healthcare technology sector. Ever Fortune. AI Co is one of the most popular companies on Eulerpool.

ROE Details

Decoding Ever Fortune. AI Co's Return on Equity (ROE)

Ever Fortune. AI Co's Return on Equity (ROE) is a fundamental metric evaluating the company's profitability relative to its equity. Calculated by dividing net income by shareholder's equity, ROE illustrates how effectively the company is generating profits from shareholders’ investments. A higher ROE represents enhanced efficiency and profitability.

Year-to-Year Comparison

Analyzing Ever Fortune. AI Co's ROE on a yearly basis aids in tracking its profitability trends and financial performance. An increasing ROE suggests enhanced profitability and value generation for shareholders, whereas a declining ROE may indicate issues in profit generation or equity management.

Impact on Investments

Ever Fortune. AI Co's ROE is instrumental for investors assessing the company's profitability, efficiency, and investment attractiveness. A robust ROE indicates the firm’s adeptness at converting equity investments into profits, thereby enhancing its appeal to potential and current investors.

Interpreting ROE Fluctuations

Changes in Ever Fortune. AI Co’s ROE can emanate from variations in net income, equity capital, or both. These fluctuations are scrutinized to evaluate management’s effectiveness, financial strategies, and the inherent risks and opportunities, aiding investors in making informed decisions.

Frequently Asked Questions about Ever Fortune. AI Co stock

Return on Equity (ROE) of Ever Fortune. AI Co is 4.97 % in 2025.

Return on Equity (ROE) of Ever Fortune. AI Co changed from 1.62 % to 4.97 %, representing a 206.43% change. The value is higher than the previous year.

On Eulerpool you can find the complete historical development of Return on Equity (ROE) Ever Fortune. AI Co since 2006 – with annual values, charts, and detailed analysis.

A 'good' varies by industry and company stage. On Eulerpool, you can compare Return on Equity (ROE)'s Ever Fortune. AI Co with sector peers and the industry average to assess whether it is attractive.

To evaluate Return on Equity (ROE)'s, it is essential to compare it with peers in the same industry and sector. On Eulerpool, you can find direct industry comparisons for Return on Equity (ROE).

Access this data via the Eulerpool API

100,000 free requests/mo · no credit card

Profitability — Ever Fortune. AI Co

All Key Metrics — Ever Fortune. AI Co